|
Volumn 159, Issue 5, 2002, Pages 755-760
|
Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
FLUORINE;
FLUOXETINE;
FLUVOXAMINE;
ADOLESCENT;
AGE;
ARTICLE;
AUTISM;
CHILD;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DEVELOPMENTAL DISORDER;
DRUG BIOAVAILABILITY;
DRUG BRAIN LEVEL;
DRUG HALF LIFE;
HUMAN;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
PRIORITY JOURNAL;
ADOLESCENT;
ADULT;
AGE FACTORS;
AUTISTIC DISORDER;
BRAIN;
BRAIN CHEMISTRY;
CHILD;
CHILD DEVELOPMENT DISORDERS, PERVASIVE;
DEPRESSIVE DISORDER;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FLUORINE;
FLUOXETINE;
FLUVOXAMINE;
HALF-LIFE;
HUMANS;
MAGNETIC RESONANCE SPECTROSCOPY;
MIDDLE AGED;
OBSESSIVE-COMPULSIVE DISORDER;
PANIC DISORDER;
SEROTONIN UPTAKE INHIBITORS;
|
EID: 0036238036
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.159.5.755 Document Type: Article |
Times cited : (42)
|
References (31)
|